Highlights

02-12 Shanghai MicroPort MedBot Co., Ltd. Announces Toumai Laparoscopic Surgical Robot Commencement of Approximately 130 Units CI
01-22 Shanghai MicroPort MedBot Expects 2025 Revenue to Jump Atleast 120% MT
01-21 Shanghai MicroPort MedBot sees adjusted net loss of not more than RMB240 million for year RE
01-21 Shanghai Microport Medbot Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025 CI
12-24 Shanghai Microport MedBot: NMPA Approves UnipathTM Electronic Bronchoscopic Surgical Robotic System RE
12-24 Shanghai Microport Medbot Co., Ltd. Approval for Unipath Electronic Bronchoscopic Surgical Robotic System by the National Medical Products Administration of China CI
12-24 Microport Medbot Reports Strong Global Momentum as Toumai Surgical Robot Orders Exceed 160 and Installations Cross 100 Units Worldwide CI
29/08/25 Shanghai MicroPort MedBot Narrows H1 Loss by 59% to 113.4 Million Yuan, Revenue Jumps 77% to 175.7 Million Yuan; Shares Rise 5% MT
28/08/25 Shanghai Microport Medbot posts H1 net loss of RMB114.9 mln RE
28/08/25 Shanghai MicroPort MedBot Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
18/07/25 Shanghai MicroPort MedBot Expects H1 Loss to Narrow; Shares Fall 1% MT
17/07/25 Shanghai Microport Medbot expects HY revenue to increase by 70%-80% RE
17/07/25 Shanghai Microport Medbot Co., Ltd. Provides Earnings Guidance for Six Months Ended June 30, 2025 CI
14/05/25 MicroPort MedBot, Controlling Shareholder to Sell Shares; Shares Fall 7% MT
23/04/25 Shanghai Microport Medbot Gets NMPA Approval For Full-Department Surgical Application Of Toumai Remote RE
23/04/25 Shanghai Microport Medbot Co., Ltd. Announces Approval for Full-Department Application of Toumai®? Laparoscopic Surgery Robot for Remote Surgery CI
28/03/25 Shanghai MicroPort MedBot 2024 Loss Shrinks; Shares Slide 5% MT
27/03/25 Shanghai MicroPort MedBot Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
03/03/25 Shanghai Microport MedBot Sees FY Revenue To Achieve Year-On-Year Growth Of 145% To 155% RE
03/03/25 Shanghai Microport Medbot Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2024 CI
12/02/25 Shanghai Microport Medbot Gets Approval For Toumai Single-Arm & Single-Port Laparoscopic Surgical Robot By NMPA RE
11/02/25 Shanghai Microport Medbot Co., Ltd. Announces Approval for Toumai Single-Arm and Single-Port Laparoscopic Surgical Robot by the National Medical Products Administration of China CI
24/01/25 Shanghai MicroPort MedBot Records Cumulative Order Volume for Core Products of Over 100 Units MT
20/01/25 Shanghai MicroPort MedBot Renews Contracts with Affiliate MT
11/12/24 Shanghai MicroPort MedBot (Group) Raises HK$266 Million via Share Placement MT
No results for this search
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW